UPDATED Jun 01, 2023
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MRKMerck KGaA | €164.15 | -1.0% | -6.1% | €71.4b | €204.22 | PE22x | E10.6% | 1.3% | ||
VSC4SC | €3.24 | -14.7% | 75.1% | €33.4m | n/a | PS75.2x | n/a | n/a | ||
MDG1Medigene | €1.62 | 2.2% | -41.1% | €39.8m | €3.00 | PS1.3x | E-10.3% | n/a | ||
EVTEvotec | €20.88 | 3.3% | -19.3% | €3.7b | €25.30 | PS4.9x | E62.0% | n/a | ||
APPHApontis Pharma | €8.74 | 2.6% | -36.0% | €72.8m | €23.67 | PE27.1x | E43.8% | n/a | ||
PJ2Liminal BioSciences | €3.80 | 0% | -0.7% | €11.8m | n/a | PS43.7x | S-149.8% | n/a | ||
HPHAHeidelberg Pharma | €3.81 | -4.0% | -24.1% | €177.5m | €8.87 | PS8.9x | E-6.8% | n/a | ||
B8FBiofrontera | €0.97 | -10.0% | -18.3% | €61.8m | €2.80 | PS2.4x | E64.8% | n/a | ||
PSGPharmaSGP Holding | €26.80 | 5.5% | 9.8% | €321.6m | €37.00 | PE26.9x | E13.0% | 1.8% | ||
2INV2invest | €6.40 | 0% | -42.1% | €36.8m | n/a | PS12.5x | n/a | n/a | ||
MORMorphoSys | €23.80 | -1.1% | 18.8% | €813.1m | €23.06 | PS2.7x | E15.3% | n/a | ||
ECX1Epigenomics | €0.63 | -1.6% | -67.3% | €2.6m | €6.00 | PS5.1x | E22.9% | n/a | ||
93M1MPH Health Care | €16.10 | 0.3% | -20.7% | €67.0m | €54.00 | PB0.4x | S81.5% | 0% | ||
PA8Paion | €5.54 | 15.3% | -40.4% | €39.5m | €20.00 | PS1.2x | n/a | n/a |